CD274 and cancer: This research should address immunological confounders, gender-specific differences in the immune response to cancer and immunotherapy as well as epigenetics, differences in PD-L1 expression and other histological or molecular biomarkers and HRQoL including gender-specific psychological aspects and treatment needs.